Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia

NAActive, not recruitingINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 31, 2023

Study Completion Date

December 31, 2025

Conditions
Alzheimer's DiseaseAlzheimer Dementia (AD)Aggression
Interventions
BEHAVIORAL

Non-Pharmacological Intervention

The behavioural intervention will be a structured implementation of individualized activities to be followed and customized as per the needs of the participant.

OTHER

Pharmacological Intervention

The medication algorithm provides recommendations to the treatment team about algorithmic treatment and assessments as per the ICP but ultimately the decision to prescribe any particular intervention will be the treatment team's decision and the recommendations of the research team for ICP arm will not be binding for the treatment team.

Trial Locations (6)

T2N 1N4

University of Calgary, Calgary

K7L 4X3

Providence Care, Kingston

N6C 2R5

LAWSON Health Research Institute, London

M6J 1H4

Centre for Addiction and Mental Health, Toronto

L1N 5S9

Ontario Shores Centre for Mental Health Sciences, Whitby

H4H 1R3

Douglas Hospital Research Centre, Montreal

All Listed Sponsors
collaborator

University of Calgary

OTHER

collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

collaborator

Douglas Mental Health University Institute

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT03672201 - Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia | Biotech Hunter | Biotech Hunter